Clinical implications of interferon-γ genetic and epigenetic variants

Nicola Smith; David Denning

doi:10.1111/imm.12362

Clinical implications of interferon-γ genetic and epigenetic variants

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	499-511
Journal	Immunology
Volume	143
Issue number	4
DOIs	https://doi.org/10.1111/imm.12362 https://doi.org/10.1111/imm.12362
Publication status	Published - 2014

Keywords

epigenetics
fungal disease
genetics
interferon-γ
tuberculosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Cite this

@article{04e0effe59d248f0ae7eb538d93c737b,

title = "Clinical implications of interferon-γ genetic and epigenetic variants",

keywords = "epigenetics, fungal disease, genetics, interferon-γ, tuberculosis",

author = "Nicola Smith and David Denning",

year = "2014",

doi = "10.1111/imm.12362",

language = "English",

volume = "143",

pages = "499--511",

journal = "Immunology",

issn = "1365-2567",

publisher = "John Wiley \& Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Clinical implications of interferon-γ genetic and epigenetic variants

AU - Smith, Nicola

AU - Denning, David

PY - 2014

Y1 - 2014

KW - epigenetics

KW - fungal disease

KW - genetics

KW - interferon-γ

KW - tuberculosis

UR - https://www.scopus.com/pages/publications/84911976919

U2 - 10.1111/imm.12362

DO - 10.1111/imm.12362

M3 - Article

C2 - 25052001

SN - 1365-2567

VL - 143

SP - 499

EP - 511

JO - Immunology

JF - Immunology

IS - 4

ER -

Clinical implications of interferon-γ genetic and epigenetic variants

Keywords

UN SDGs

Access to Document

Other files and links

Cite this